Kwan‐Lung Ko

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

Wai‐Kay Seto, K. S. H. Liu, Lung‐Yi Mak et al. · Gut · 2020 · 87 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Hepatocellular carcinoma: recent advances and emerging medical therapies

Kwan‐Lung Ko, Lung‐Yi Mak, Ka Shing Cheung et al. · F1000Research · 2020 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy

Lung‐Yi Mak, Qi Huang, Danny Ka‐Ho Wong et al. · Journal of Gastroenterology · 2021 · 50 citations

Medicine, Molecular Biology, Oncology +15

A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong Kong

Kevin S.H. Liu, Wai‐Kay Seto, Eric H. Y. Lau et al. · The Journal of Infectious Diseases · 2019 · 44 citations · Full text

Veterinary Medicine, Community Health, Infectious Diseases +16

A large real‐world cohort study examining the effects of long‐term entecavir on hepatocellular carcinoma and HBsAg seroclearance

Kwan‐Lung Ko, Wai‐Pan To, Lung‐Yi Mak et al. · Journal of Viral Hepatitis · 2019 · 22 citations

Medicine, Oncology, Pharmacotherapy +13